Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1681 AL 1695

Cellular phenotypes as inflammatory mediators in Parkinson's disease: Interventional targets and role of natural products

Jiang X, Ganesan P, Rengarajan T, Choi DK, Arulselvan P.

Biomed Pharmacother. 2018 Oct;106:1052-1062. doi: 10.1016/j.biopha.2018.06.162. Epub 2018 Jul 17.

Unstable impedance of a single electrode contact resulting in loss of DBS therapy-a case report

Allert N, Lindlau A, Quindt R, Reker P, Timmermann L, Barbe MT.

Acta Neurochir (Wien). 2018 Dec;160(12):2485-2488. doi: 10.1007/s00701-018-3658-x. Epub 2018 Aug 17.

An updated analysis with 45,078 subjects confirms the association between SNCA rs11931074 and Parkinson's disease

Liu X, Zhu R, Xiao T, Li Q, Zhu Y, He Z.

Neurol Sci. 2018 Dec;39(12):2061-2069. doi: 10.1007/s10072-018-3538-4. Epub 2018 Aug 17.

Three-dimensional histologic reconstruction of remnant functional accessory atrioventricular myocardial connections in a case of Wolff-Parkinson-White syndrome

Matsuyama TA, Haraguchi R, Nakashima J, Kusano K, Ishibashi-Ueda H.

Cardiovasc Pathol. 2018 Nov-Dec;37:1-4. doi: 10.1016/j.carpath.2018.07.003. Epub 2018 Jul 27.

Virtual Reality for Neurorehabilitation: Insights From 3 European Clinics

O'Neil O, Fernandez MM, Herzog J, Beorchia M, Gower V, Gramatica F, Starrost K, Kiwull L.

PM R. 2018 Sep;10(9 Suppl 2):S198-S206. doi: 10.1016/j.pmrj.2018.08.375. Epub 2018 Aug 16.

Impact of Tremor on Patients With Early Stage Parkinson's Disease

Heusinkveld LE, Hacker ML, Turchan M, Davis TL, Charles D.

Front Neurol. 2018 Aug 3;9:628. doi: 10.3389/fneur.2018.00628. eCollection 2018.

Meta-Analysis of Visual Evoked Potential and Parkinson's Disease

He SB, Liu CY, Chen LD, Ye ZN, Zhang YP, Tang WG, Wang BD, Gao X.

Parkinsons Dis. 2018 Jul 11;2018:3201308. doi: 10.1155/2018/3201308. eCollection 2018.

Emerging and Alternative Therapies For Parkinson Disease: An Updated Review

Kabra A, Sharma R, Kabra R, Baghel US.

Curr Pharm Des. 2018;24(22):2573-2582. doi: 10.2174/1381612824666180820150150.

Cognition among individuals along a spectrum of increased risk for Parkinson's disease

Chahine LM, Urbe L, Caspell-Garcia C, Aarsland D, Alcalay R, Barone P, Burn D, Espay AJ, Hamilton JL, Hawkins KA, Lasch S, Leverenz JB, Litvan I, Richard I, Siderowf A, Coffey CS, Simuni T, Weintraub D; Parkinson’s Progression Markers Initiative.

PLoS One. 2018 Aug 20;13(8):e0201964. doi: 10.1371/journal.pone.0201964. eCollection 2018.

Balancing between the two: Are freezing of gait and postural instability in Parkinson's disease connected?

Bekkers EMJ, Dijkstra BW, Heremans E, Verschueren SMP, Bloem BR, Nieuwboer A.

Neurosci Biobehav Rev. 2018 Nov;94:113-125. doi: 10.1016/j.neubiorev.2018.08.008. Epub 2018 Aug 17.

Rescue of Fmr1(KO) phenotypes with mGluR(5) inhibitors: MRZ-8456 versus AFQ-056

Westmark PR, Dekundy A, Gravius A, Danysz W, Westmark CJ.

Neurobiol Dis. 2018 Nov;119:190-198. doi: 10.1016/j.nbd.2018.08.008. Epub 2018 Aug 17.

Neuroprotection by immunomodulatory agents in animal models of Parkinson's disease

Martinez B, Peplow PV.

Neural Regen Res. 2018 Sep;13(9):1493-1506. doi: 10.4103/1673-5374.237108.

Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases

Konishi H, Kiyama H.

Front Cell Neurosci. 2018 Aug 6;12:206. doi: 10.3389/fncel.2018.00206. eCollection 2018.

Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention

Ferreira SA, Romero-Ramos M.

Front Cell Neurosci. 2018 Aug 6;12:247. doi: 10.3389/fncel.2018.00247. eCollection 2018.

Models of Parkinson's Disease with Special Emphasis on Drosophila melanogaster

Fatima A, Jyoti S, Siddique YH.

CNS Neurol Disord Drug Targets. 2018;17(10):757-766. doi: 10.2174/1871527317666180820164250.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias